StockData
Galectin Therapeutics Inc logo

Galectin Therapeutics Inc (GALT) stock

GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.98+0.07 (+2.41%)

Close on Nov 18, 2026Market cap $300.53MP/E –Yield –

Galectin Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Galectin Therapeutics's pe ratio was 21.0× on Jan 31, 2019.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Jan 31, 201921.0×+6.1
2018Dec 31, 201814.9×–

More Galectin Therapeutics figures

See a number that looks wrong?